BIA-ALCL was included as a new entity in the current WHO classification as a NHL characterized by a monoclonal population of large anaplastic cells which are uniformly CD30-positive and ALK negative and variably expressing T cell markers and EMA [9]. Here, ALK is linked to non-Hodgkin lymphoma.